Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Race Oncology.
RELATED STOCKHEAD STORIES
Health & Biotech
ASX Health: Twiggy Forrest’s investment fund takes a stake in this ASX cannabis stock
Health & Biotech
ASX Health Stocks: Pharmaxis jumps 9pc on FDA approval
Director Trades
Directors’ Trades: This week’s list of traders includes three noteworthy fund managers
News
Closing Bell: ASX fails to maintain gains, despite tech gaining 1.7pc
Health & Biotech
ASX Health Stocks: Alterity moves to Phase 2 on cancer drug, Race Oncology secures 6th US patent
News
Closing Bell: ASX has its best day of the year, but not enough to avoid 3pc dip in September
Director Trades
Director Trades: Nearly 50 directors spent more than $100k each on trades this past fortnight
Health & Biotech
Check up: Rhinomed (ASX:RNO) soars with NSW COVID contract, and genetic testing fails to impress
News
Closing Bell: ASX finishes flat
Stockhead TV
V-Con: Talking medical innovations and breakthrough treatments with ASX biotechs
Health & Biotech
Suda Pharma pops 44pc on cap raise; Acrux and other biotechs whet investor appetites
News
Last Orders: ASX rebounds after yesterday’s sharp drop
Health & Biotech
‘Miracle’ breakthrough in melanoma fight puts focus on ASX stocks in the skin cancer space
News
Last Orders: ASX rebounds 1 per cent after yesterday’s plunge
Experts
ScoPo’s Powerplays: Health sector trades sideways but M&A plays coloured the week
News
Last Orders: ASX edges further towards pre-pandemic record high
Experts
